Prosight Management »

Corbus Pharmaceuticals Hldgs shares owned by Prosight Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.9M 101k 39.24

More positions owned by Prosight Management

Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Kura Oncology (KURA)
Roivant Sciences SHS (ROIV)
Bridgebio Pharma (BBIO)
Cytokinetics Com New (CYTK)
Medtronic SHS (MDT)
Orthopediatrics Corp. (KIDS)
Mirum Pharmaceuticals (MIRM)
Guardant Health (GH)
Kelly Svcs Cl A (KELYA)
Abcellera Biologics (ABCL)
Erasca (ERAS)

View all positions for Prosight Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Point72 Asset Management
Ikarian Capital
Vanguard Group
Adage Capital Partners GP
Octagon Capital Advisors
Citadel Advisors
Henderson Group
Millennium Management
Assenagon Asset Management
BlackRock
T. Rowe Price Associates
Barclays
Morgan Stanley
Boothbay Fund Management

View all funds holding Corbus Pharmaceuticals Hldgs